MUFG Securities Americas’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$329K Buy
1,451
+89
+7% +$15.8K 0.02% 476
2026
Q1
$235K Buy
1,362
+36
+3% +$6.67K 0.02% 481
2025
Q4
$265K Sell
1,326
-1
-0.1% -$181 0.02% 481
2025
Q3
$208K Buy
1,327
+239
+22% +$38K 0.01% 492
2025
Q2
$165K Buy
1,088
+182
+20% +$24.3K 0.01% 490
2025
Q1
$136K Buy
906
+151
+20% +$25.3K 0.02% 490
2024
Q4
$139K Buy
+755
New +$145K 0.02% 479

Other funds holding CRL

MUFG Securities Americas's CRL Position: Q2 2026 in Review

MUFG Securities Americas increased its Charles River Laboratories (CRL) stake by 6.5% in Q2 2026, buying an estimated $15.8K and bringing the position to 1,451 shares worth $329K. The position accounts for 0.02% of the portfolio, ranked #476.

MUFG Securities Americas first reported a position in CRL in Q4 2024 and has held it in 7 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • MUFG Securities Americas held 1,451 shares of Charles River Laboratories worth $329K as of Q2 2026.
  • MUFG Securities Americas bought 89 Charles River Laboratories shares in Q2 2026, an estimated $15.8K.
  • Charles River Laboratories made up 0.02% of MUFG Securities Americas's portfolio in Q2 2026, its #476 holding.
  • MUFG Securities Americas first reported a position in Charles River Laboratories in Q4 2024 and has held it in 7 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on MUFG Securities Americas's 13F filing for Q2 2026, filed 14 Aug 2026.